Author(s): Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC
Problem/condition: Chronic obstructive pulmonary disease (COPD) includes chronic bronchitis and emphysema but has been defined recently as the physiologic finding of nonreversible pulmonary function impairment. This surveillance summary reports trends in different measures of COPD during 1971-2000.
Reporting period covered: This report presents national data regarding objectively determined COPD (1971-1994); COPD-associated activity and functional limitations (1980-1996); self-reported COPD prevalence, COPD physician office and hospital outpatient department visits, COPD hospitalizations, and COPD deaths (1980-2000); and COPD emergency department visits (1992-2000).
Description of systems: CDC's National Center for Health Statistics (NCHS) conducts the National Health Interview Survey annually, which includes questions concerning COPD and activity limitations. NCHS collects physician office-visit data in the National Ambulatory Medical Care Survey, emergency department and hospital outpatient department data in the National Hospital Ambulatory Medical Care Survey, hospitalization data in the National Hospital Discharge Survey, and death data in the Mortality Component of the National Vital Statistics System. Data regarding pulmonary function were obtained from the National Health and Nutrition Examination Surveys (NHANES) I (1971-1975) and III (1988-1994), and data regarding functional limitation were obtained from NHANES III, Phase 2 (1991-1994).
Results: During 2000, an estimated 10 million U.S. adults reported physician-diagnosed COPD. However, data from NHANES III estimate that approximately 24 million U.S. adults have evidence of impaired lung function, indicating that COPD is underdiagnosed. During 2000, COPD was responsible for 8 million physician office and hospital outpatient visits, 1.5 million emergency department visits, 726,000 hospitalizations, and 119,000 deaths. During the period analyzed, the most substantial changes was the increase in the COPD death rate for women, from 20.1/100,000 in 1980 to 56.7/100,000 in 2000, compared with the more modest increase in the death rate for men, from 73.0/100,000 in 1980 to 82.6/100,000 in 2000. In 2000, for the first time, the number of women dying from COPD surpassed the number of men dying from COPD (59,936 versus 59,118). Another substantial change observed is that the proportion of the population aged < 55 years with mild or moderate COPD, on the basis of pulmonary function testing, decreased from 1971-1975 to 1988-1994, possibly indicating that the upward trends in COPD hospitalizations and mortality might not continue.
Interpretation: COPD is a major cause of morbidity, mortality, and disability in the United States. Despite its ease of diagnosis, COPD remains an underdiagnosed disease, chiefly in its milder and more treatable form.
Referred From: https://www.ncbi.nlm.nih.gov/pubmed/12198919
Author(s): Mannino DM
Author(s): Xu X, Weiss ST, Rijcken B, Schouten JP
Author(s): Anthonisen NR, Connett JE, Murray RP
Author(s): Guyatt GH, Townsend M, Pugsley SO, Keller JL, Short HD, et al.
Author(s): Man WD, Mustfa N, Nikoletou D, Kaul S, Hart N, et al.
Author(s): Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, et al.
Author(s): Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM, et al.
Author(s): Sin DD, McAlister FA, Man SF, Anthonisen NR
Author(s): Ram FS, Jones PW, Castro AA, DeBerito JA, Atallah AN, et al.
Author(s): Highland KB, Strange C, Heffner JE
Author(s): Sutherland ER, Allmers H, Ayas NT, Venn AJ, Martin RJ
Author(s): Alsaeedi, Sin DD, McAlister FA
Author(s): Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, et al.
Author(s): Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, et al.
Author(s): Mahler DA, Wire P, Horstman D, Chang C, Yates J, et al.
Author(s): Szafranski W, Cukier A, Ramirez A, Menga G, Sansores R, et al.
Author(s): Hanania NA, Darken P, Horstman D, Reisner C, Lee B, et al.
Author(s): Calverley PM, Boonsawat W, Cseke Z, Zhong N, Peterson S, et al.
Author(s): Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, et al.
Author(s): Rice KL, Rubins JB, Lebahn F, Parenti CM, Duane PG, et al.
Author(s): Decramer M, Lacquet LM, Fagard R, Rogiers P
Author(s): Decramer M, Stas KJ
Author(s): Chong J, Poole P, Leung B, Black PN
Author(s): Calverley PM, Rabe KF, Goehring UM, Kristiansen S, Fabbri LM, et al.
Author(s): Seemungal TA, Wilkinson TM, Hurst JR, Perera WR, Sapsford RJ, et al.
Author(s): He ZY, Ou LM, Zhang JQ, Bai J, Liu GN, et al.
Author(s): Wongsurakiat P, Lertakyamanee J, Maranetra KN, Jongriratanakul S, Sangkaew S
Author(s): Granger R, Walters J, Poole PJ, Lasserson TJ, Mangtani P, et al.
Author(s): Centers for Disease Control and Prevention
Author(s): Nocturnal Oxygen Therapy Trial Group
Author(s): Takabatake N, Nakamura H, Abe S, Inoue S, Hino T, et al.
Author(s): Heindl S, Lehnert M, Criee CP, Hasenfuss G, Andreas S
Author(s): Bratel T, Wennlund A, Carlstrom K
Author(s): Guyatt GH, McKim DA, Austin P, Bryan R, Norgren J, et al.
Author(s): Griffiths TL, Burr ML, Campbell IA, Lewis-Jenkins V, Mullins J, et al.
Author(s): Mehran RJ, Deslauriers J
Author(s): Moayyedi P, Congleton J, Page RL, Pearson SB, Muers MF
Author(s): Thompson WH, Nielson CP, Carvalho P, Charan NB, Crowley JJ
Author(s): Davies L, Angus RM, Calverley PM
Author(s): Niewoehner DE, Erbland ML, Deupree RH, Collins D, Gross NJ, et al.
Author(s): Maltais F, Ostinelli J, Bourbeau J, Tonnel AB, Jacquemet N, et al.
Author(s): Sethi S, Evans N, Grant BJ, Murphy TF
Author(s): Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, et al.
Author(s): Jorgensen AF, Coolidge J, Pedersen PA, Peterson KP, Waldorff S, et al.